Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Hemoglobin, Albumin, Lymphocyte, Platelet (HALP) Score in Distinction Between Fetal Growth Restriction (FGR) and Small for Gestational Age (SGA)

NCT05814198 is registered in ClinicalTrials.gov with Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization as lead sponsor.

NCT NCT05814198
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05814198 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Hemoglobin, Albumin, Lymphocyte, Platelet (HALP) Score in Distinction Between Fetal Growth Restriction (FGR) and Small for Gestational Age (SGA)
Lead sponsor
Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization
Phase
Observational
Overall status
Completed
Start date
February 22, 2023
Completion date
June 15, 2023
Enrollment
400 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fetal growth restriction, small for gestational age at delivery